Nonprofit · EIN 04-3554536
DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC
Tax-exempt · BOSTON, MA 02215
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| September 30, 2025 | 990 | $0 | $275,738 | -$275,738 | $0 | $0 | $0 |
| September 30, 2024 | 990 | $0 | $250,724 | -$250,724 | $0 | $0 | $0 |
| September 30, 2023 | 990 | $0 | $296,404 | -$296,404 | $0 | $0 | $0 |
Financial details: 990 for the year ended September 30, 2025
Revenue
- Contributions, gifts and grants
- $0
- Program service revenue
- $0
- Investment income
- $0
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $0
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $0
- Program services (functional)
- $275,738
Balance sheet and other
- Total assets, start of year
- $0
- Total assets, end of year
- $0
- Total liabilities, end of year
- $0
- Net assets, end of year
- $0
- Gross receipts
- $0
- Employees
- 0
- Volunteers
- 0
- Year formed
- 2000
- State of legal domicile
- MA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended September 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Kevin Churchwell MD | Trustee Trustee or director | 1 | $0 | $3,311,889 | $178,434 |
| Laurie Glimcher MD | Trustee (End Term 10/2024) Trustee or director | 1 | $0 | $2,313,019 | $366,631 |
| Doug Vanderslice | Treasurer Officer | 1 | $0 | $1,859,177 | $94,499 |
| Laura Wood DNP MS RN | Trustee Trustee or director | 1 | $0 | $1,307,311 | $104,584 |
| Scott Armstrong MD | President (End Term 10/2024) Officer | 1 | $0 | $843,326 | $84,542 |
| Andrew Place MD PhD | Chief Medical Officer (Begin Term 2/2025) Officer | 1 | $0 | $654,992 | $87,660 |
| David Williams MD | President (Begin Term 10/2024) Officer | 1 | $0 | $634,733 | $73,813 |
| Lisa Diller MD | Chief Medical Officer (End Term 10/2024) Officer | 1 | $0 | $566,700 | $57,458 |
| Benjamin L Ebert MD PhD | Trustee (Begin Term 10/2024) Trustee or director | 1 | $0 | $468,091 | $63,424 |
| Krietta Bowens Jones | Clerk Officer | 1 | $0 | $288,520 | $63,998 |
| Gary Fleisher MD | Trustee (End Term 10/2024) Trustee or director | 1 | $0 | $0 | $0 |
| Stephen Karp | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| Andrew J Janower | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| Robert Smith | Chair & Trustee Trustee or director, Officer | 1 | $0 | $0 | $0 |
| Nancy Gibson | Trustee Trustee or director | 1 | $0 | $0 | $0 |
1 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Brad Lucas | Trustee Trustee or director | 1 | $0 |
990 for the year ended September 30, 2024: 14 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Kevin Churchwell MD | Trustee Trustee or director | 1 | $0 | $3,062,633 | $135,259 |
| Laurie Glimcher MD | Trustee Trustee or director | 1 | $0 | $2,105,144 | $354,681 |
| Doug Vanderslice | Treasurer Officer | 1 | $0 | $1,604,073 | $80,122 |
| Laura Wood DNP MS RN | Trustee Trustee or director | 1 | $0 | $1,005,064 | $74,650 |
| Scott Armstrong MD | President Officer | 1 | $0 | $819,691 | $81,122 |
| Lisa Diller MD | Chief Medical Officer Officer | 1 | $0 | $549,768 | $55,049 |
| Krietta Bowens Jones | Clerk Officer | 1 | $0 | $277,636 | $62,414 |
| Gary Fleisher MD | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| Stephen Karp | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| Andrew J Janower | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| Robert Smith | Chair & Trustee Trustee or director, Officer | 1 | $0 | $0 | $0 |
| Nancy Gibson | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| Brad Lucas | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| Karen Linde Packman | Trustee (END TERM 10/16/23) Trustee or director | 1 | $0 | $0 | $0 |
990 for the year ended September 30, 2023: 13 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Kevin Churchwell MD | Trustee Trustee or director | 1 | $0 | $3,239,502 | $125,802 |
| Laurie Glimcher MD | Trustee Trustee or director | 1 | $0 | $2,000,525 | $338,932 |
| Doug Vanderslice | Treasurer Officer | 1 | $0 | $1,981,768 | $75,202 |
| Sandra Fenwick | Former Trustee Former | 0 | $0 | $958,796 | $0 |
| Scott Armstrong MD | President Officer | 1 | $0 | $801,450 | $73,627 |
| Lisa Diller MD | Chief Medical Officer Officer | 1 | $0 | $525,188 | $51,520 |
| Krietta Bowens Jones | Clerk Officer | 1 | $0 | $263,189 | $56,092 |
| Gary Fleisher MD | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| Stephen Karp | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| AJ Janower | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| Karen Linde Packman | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| Robert Smith | Trustee Trustee or director | 1 | $0 | $0 | $0 |
| Beth Terrana | Trustee Trustee or director | 1 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 450 BROOKLINE AVENUE BP418, BOSTON, MA 02215-5418
- In care of
- % RICHARD S BOSKEY
- Principal officer (990 for 2024)
- David Williams MD, 300 Longwood Avenue, Boston, MA 02115
- Signed the 990
- Doug Vanderslice, Treasurer
- Phone
- (888) 733-4662
- Return prepared by
- Ernst & Young LLP
Mission
To oversee, coordinate and support the Pediatric Oncology Programs at Boston Children's Hospital and Dana-Farber Cancer Institute, Inc.
Program accomplishments
- Dana-Farber/Children's Hospital Cancer Care, Inc. ("DF/CHCC") is a Massachusetts charitable corporation organized on December 14, 2000, whose members are The Children's Hospital Corporation ("Children's") and Dana-Farber Cancer Institute, Inc. ("Dana-Farber"). Its primary purpose is to oversee, coordinate and support the Pediatric Oncology Program (the "Joint Program"). It also, formalizes the pediatric oncology partnership that has existed between Dana-Farber and Boston Children's since 1947.The Joint Program, which is the largest pediatric oncology program in New England and one of the most active in the country, offers the combined expertise of both a world-class cancer center and an internationally renowned children's hospital. Neighboring institutes connected by pedestrian bridges, Dana-Farber Cancer Institute and Boston Children's Hospital work together to offer seamless, integrated care for children with all types of cancer and blood disorders including the rarest and most complex cases. Through our joint partnership, Dana-Farber/Boston Children's offers more specialists, more treatment options, and more clinical trials than almost any other pediatric center treating cancer and blood disorders in the world.Our Expertise in Treating Pediatric Cancer and Blood Disorders: Our hematologists and oncologists are among the world leaders in their respective specialties; many have pioneered treatments that have been adopted by medical communities around the globe. Our doctors also collaborate with teams of expert subspecialists to provide truly comprehensive care for our patients. Innovative Approaches:Our history of research and innovation has resulted in many of the diagnostic and therapeutic techniques currently used around the world to treat cancer and blood disorders. Today, we continue to stand among the world's leaders in many innovative approaches.Our research, clinical trials, and state-of-the art treatment facilities allow our care teams to provide the safest and most effective care possible.Some of our innovative approaches include:- The Advancing Childhood Cancer Therapies (ACCT) Clinic offers clinical trials for relapsed and refractory cancer. CAR T-cell therapy is a promising new treatment for some of the most challenging cases we face in pediatric leukemia and lymphoma. - Gene therapy delivers DNA into a patient's cells to replace faulty or missing genes or to add new genes in an attempt to cure a disease or make changes so the body is better able to fight off disease. - Immunotherapy is the treatment of disease by inducing, enhancing, or suppressing an immune response. Cancer immunotherapy attempts to stimulate the immune system to reject or destroy tumors.- MIBG therapy is a special treatment for children with refractory or relapsed neuroblastoma. We are one of only a handful of centers in the United States equipped for this type of treatment. - Our Pediatric Cancer Genetic Risk Program provides cancer risk assessment and comprehensive recommendations for managing cancer risk. We also conduct research into many aspects of cancer risk and its management.- Precision medicine allows doctors to tailor treatment to the specific genetic characteristics of a patient's cancer. Dana-Farber/Boston Children's is involved in one of the country's most comprehensive precision cancer medicine initiatives.Conditions we treat: Utilizing proven treatment protocols and innovative therapies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center treats over 100 forms of cancer and blood disorders in children and young adults, including:- Blood Disorders - Our Blood Disorders Center provides comprehensive care for a wide range of non-malignant blood disorders including anemia, hemophilia, myelodysplastic syndrome, sickle cell disease and thalassemia. - Brain Tumors - The specialists in our Brain Tumor Center have the expertise to treat a wide range of malignant brain tumors, including atypical teratoid rhabdoid tumor (AT/RT), diffuse pontine glioma and germ cell tumors of the brain.- Leukemia, Lymphoma, and Histiocytosis - The specialists in our Hematologic Malignancies Center are world leaders in the treatment of pediatric leukemia and lymphoma as well as the primary types of histiocytosis.- Solid Tumors - Our Solid Tumor Center provides advanced treatment, including surgery, for a wide range of solid tumors, including bone tumors like osteosarcoma, soft tissue tumors, neuroblastoma, kidney tumors and liver tumors. - Other Conditions We Treat - The specialists at Dana-Farber/Boston Children's also participate in the care of children and teens with a variety of conditions that do not come under the umbrella of cancers or blood disorders. These other conditions include genetic immunodeficiencies, metabolic disorders, vascular anomalies, and cardiovascular diseases such as pulmonary hypertension and pulmonary vein stenosis.Expenses $275,738
What it must file and when
IRS records say it files Form 990-N (e-Postcard). Gross receipts normally $50,000 or less. Its accounting year ends in September, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | September 30, 2026 | February 16, 2027 | Not due yet |
| 2024 | September 30, 2025 | February 17, 2026 | 990 on file |
| 2023 | September 30, 2024 | February 18, 2025 | 990 on file |
IRS record
- EIN
- 04-3554536
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Supporting organization (509(a)(3))
- Donations deductible (Pub 78)
- Supporting organization of unknown type
- Exempt since
- 2002
- Accounting year ends
- September
- Files
- Form 990-N (e-Postcard)
- Category (NTEE)
- Health care (E022)
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | September 2025 | $0 | $275,738 | $0 | XML |
| 990 | September 2024 | $0 | $250,724 | $0 | XML |
| 990 | September 2023 | $0 | $296,404 | $0 | XML |
| 990 | September 2022 | $0 | $254,184 | $0 | IRS |
| 990 | September 2021 | – | – | – | IRS |
| 990 | September 2020 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 04-3554536).
Questions about DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC
- What is the EIN of DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC?
- The employer identification number (EIN) of DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC is 04-3554536.
- Is DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2002.
- Are donations to DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Supporting organization of unknown type).
- Which annual return does DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC file?
- Form 990-N (e-Postcard). Gross receipts normally $50,000 or less.
- When is the next return of DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC due?
- The return for tax year 2025 (the year ending September 30, 2026) is due February 16, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended September 2025.
- Who is the principal officer of DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC?
- The 990 for the year ended September 30, 2025 names David Williams MD.
- Who are the officers and directors of DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC?
- The 990 for the year ended September 30, 2025 lists 16 people; 0 received compensation from the organization.
- How much revenue does DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC have?
- On its 990 for the year ended September 30, 2025 it reported revenue of $0, expenses of $275,738 and total assets of $0 at year end.
Other nonprofits in BOSTON
- CHILDRENS HOSPITAL CORPORATION EIN 04-2774441 · last filed 990 for 2025
- BOSTON MEDICAL CENTER CORPORATION EIN 04-3314093 · last filed 990 for 2025
- COMMONWEALTH CARE ALLIANCE INC EIN 04-3756900 · last filed 990 for 2024
- HARVARD MEDICAL FACULTY PHYS AT BETH ISRAEL DEACONESS MED CTR INC EIN 22-2768204 · last filed 990 for 2025
- CHILDRENS MEDICAL CENTER EIN 04-1174680 · last filed 990 for 2025
- CHILDRENS HOSPITAL PEDIATRIC ASSOCIATES INC EIN 43-1987409 · last filed 990 for 2025
- BOSTON MEDICAL CENTER-SOUTH CORPORATION EIN 99-4491180 · last filed 990 for 2025
- BOSTON MEDICAL CENTER-BRIGHTON CORPORATION EIN 99-4793550 · last filed 990 for 2025